DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Yoshinaga K, Oriuchi N, Wakabayashi H. et al.
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
ENDOCR J 2014;
61: 1171-1180
DOI: 10.1507/endocrj.EJ14-0211. (PMID: 25214026)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.